Anebulo Pharmaceuticals (ANEB) Other financing activities (2022)
Anebulo Pharmaceuticals (ANEB) posted quarterly Other financing activities of $52400.0 for Q3 2022.
Anebulo Pharmaceuticals (ANEB) Other financing activities (2022) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Other financing activities for 1 consecutive years, with $52400.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Other financing activities changed N/A year-over-year to $52400.0; the TTM figure through Jun 2023 stood at $52400.0 (changed N/A YoY), while the FY2025 annual figure was $116664.0, up 87.1% from the prior year.
- Other financing activities held at $52400.0 in Q3 2022 per ANEB's latest filing.
- Across five years, Other financing activities topped out at $52400.0 in Q3 2022 and bottomed at $52400.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 52,400.00 |
| Sep 30, 2022 | 52,400.00 |